LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 67 filers reported holding LARIMAR THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CHI Advisors LLC | 3,414,468 | $13,487,148 | 5.35% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 16,941,357 | $66,918,360 | 1.47% |
Opaleye Management Inc. | 848,500 | $3,351,575 | 1.09% |
DAFNA Capital Management LLC | 327,373 | $1,293,123 | 0.40% |
Ikarian Capital, LLC | 682,868 | $2,697,329 | 0.32% |
Atlas Venture Advisors, Inc. | 292,184 | $1,154,127 | 0.24% |
MANGROVE PARTNERS IM, LLC | 805,815 | $3,182,969 | 0.24% |
Verition Fund Management LLC | 2,900,538 | $11,457,125 | 0.13% |
Fi3 FINANCIAL ADVISORS, LLC | 25,571 | $101,005 | 0.05% |
UBS OCONNOR LLC | 378,505 | $1,495,095 | 0.04% |
Woodline Partners LP | 709,681 | $2,803,240 | 0.03% |
GSA CAPITAL PARTNERS LLP | 89,213 | $352 | 0.03% |
Golden State Equity Partners | 23,800 | $94,010 | 0.03% |
Solstein Capital, LLC | 4,477 | $17,684 | 0.02% |
BOOTHBAY FUND MANAGEMENT, LLC | 147,203 | $581,452 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 112,800 | $445,560 | 0.01% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,176,680 | $4,647,886 | 0.01% |
JOURNEY STRATEGIC WEALTH LLC | 35,260 | $139,277 | 0.01% |
J. Goldman & Co LP | 54,000 | $213,300 | 0.01% |
JANUS HENDERSON GROUP PLC | 2,461,462 | $9,710,468 | 0.01% |
External links
This page lists LARIMAR THERAPEUTICS INC's shareholders in Q3 2023. To view LARIMAR THERAPEUTICS INC's shareholder history, click here.